It is the European Medicines Agency (EMA) that assesses whether a vaccine can be marketed. “And all vaccines will be properly assessed before being authorized,” said Commission President von der Leyen.
Two vaccines, that of Pfizer / BioNTech and Moderna, may be licensed this year. “If all goes well without any problems, EMA could grant conditional marketing authorization in the second half of December,” von der Leyen was told by the European Medicines Agency, which consults daily with the US counterpart FDA.
–
Related posts:
Sugar, the product that became most expensive in the world in September: FAO
European stocks continue to rise and await 'inflation indicators'
NOAH produces Roman wooden watches with Swiss movements / The Chinese want to make them for the bran...
Egyptian Banks Controversy: What's the Truth Behind the 40% Certificates?
